McNeil Children's Motrin Combination Suspension Creates New Category
This article was originally published in The Tan Sheet
Executive Summary
McNeil Consumer Healthcare has received the go-ahead to launch the first ibuprofen/pseudoephedrine OTC pediatric product following FDA's approval of its NDA for Children's Motrin Cold Suspension Aug. 1.
You may also be interested in...
Direct-To-OTC Approvals, Line Extensions Replace Switches In 2000
Direct-to-OTC drug introductions and line extensions dominated the list of new product rollouts in 2000. The year marked the first time since 1993 that no Rx-to-OTC switches were approved, although FDA reviewed several switch candidates.
Direct-To-OTC Approvals, Line Extensions Replace Switches In 2000
Direct-to-OTC drug introductions and line extensions dominated the list of new product rollouts in 2000. The year marked the first time since 1993 that no Rx-to-OTC switches were approved, although FDA reviewed several switch candidates.
Direct-To-OTC Approvals, Line Extensions Replace Switches In 2000
Direct-to-OTC drug introductions and line extensions dominated the list of new product rollouts in 2000. The year marked the first time since 1993 that no Rx-to-OTC switches were approved, although FDA reviewed several switch candidates.